Table 4 ABO blood group distribution of lung adenocarcinoma and control group in Multicenter.

From: Platelet indicators do not influence the impact of ABO blood groups on lung adenocarcinoma susceptibility

Center

Classes

n

ABO blood group phenotype

p

A

B

O

AB

Multicenter

Control group

1980

643(32.5%)

481(24.3%)

666(33.6%)

190(9.6%)

 

Lung adenocarcinoma group

1980

530(26.8%)

574(29.0%)

713(36.0%)

163(8.2%)

0.000